Concord Healthcare Group Co., Ltd. (HKG: 2453)

Market Cap	19.20B
Revenue (ttm)	507.66M
Net Income (ttm)	-387.56M
Shares Out	716.34M
EPS (ttm)	-0.56
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	155,600
Open	28.50
Previous Close	28.40
Day's Range	26.80 - 29.00
52-Week Range	9.70 - 55.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Concord Healthcare Group

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People’s Republic of China. It operates in two segments, Hospital Business; and Medical Equipment, Software and Related Services. The company also offers oncology-related services, including sales and installing of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipme...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2008
• Employees: 733
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2453

Financial Performance

In 2023, Concord Healthcare Group's revenue was 538.65 million, an increase of 14.08% compared to the previous year's 472.17 million. Losses were -373.09 million, -31.09% less than in 2022.

Financial numbers in CNY